Posted on 7440
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: “This support from both our existing as well as our new shareholders will accelerate the advancement of our two lead small molecule programs towards the clinic for the potential treatment of Alzheimer’s disease and various synucleinopathies including Parkinson’s disease.”
Press release content from Business Wire. The AP news staff was not involved in its creation.
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
January 25, 2021 GMT
CAMBRIDGE, United Kingdom (BUSINESS WIRE) Jan 25, 2021
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
Numerous Indian American STEM Researchers Named Fellows of American Association for the Advancement of Sciences indiawest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiawest.com Daily Mail and Mail on Sunday newspapers.
First Pakistani space scientist at the University of Cambridge wins 2020’s Young Leaders Award
>Dr Yarjan Abdul Samad is a Senior Research Associate and a Teaching Fellow at Cambridge Graphene Centre, The Department of Engineering at The University of Cambridge. He is also the first Space Scientist hailing from Pakistan at the University of Cambridge where he has won several awards for his research work.
The latest addition to his awards is the Young Leaders Award for 2020 by the Young Professionals Society (YPS). Dr Yarjan is currently working on a research project on loop heat pipes for use in space applications and he was part of the European Space Agency zero-gravity flight campaign held in Nov-Dec 2017.
AI 版 Nature Index 排名，两种结果折射中国 AI 实力软肋_BAAIBeijing的博客-CSDN博客 csdn.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from csdn.net Daily Mail and Mail on Sunday newspapers.